Cafe Sci - Gene Therapy in Sickle Cell Disease with Suchi Pandey, MD
Gene therapy is currently undergoing clinical trials to evaluate its effectiveness at treating sickle cell disease. In this talk, Dr. Suchi Pandey will review how gene therapy is currently being used to treat sickle cell disease, the different kinds of gene therapy options being evaluated, and the potential impact to transfusion requirements before, during and after the treatment. Dr. Suchi Pandey is currently one of Stanford Blood Center's Chief Medical Officers. Her responsibilities include providing medical support to blood center staff, management of blood donor medical issues, development of blood center medical policy, oversight of blood center operations, consultation with Stanford Hospital for patient management and the teaching/supervision of fellows and residents. She is currently also one of the blood center’s CLIA Lab Directors. Dr. Pandey received an MD from Drexel University’s College of Medicine in Philadelphia. She did her residency in Anatomic and Clinical Pathology at the University of California, San Diego, and completed a one-year Transfusion Medicine fellowship at the University of California, San Francisco and Blood Centers of the Pacific. She is Board Certified in Anatomic & Clinical Pathology and in Transfusion Medicine. Before joining the Stanford Blood Center team, Dr. Pandey spent eight years as the Chief Medical Officer at Blood Centers of the Pacific and two years as an Assistant Medical Director in the UCSF Transfusion Service. Dr. Pandey is actively involved in the transfusion medicine community and currently serves on the board of the California Blood Bank Society. She is also co-chair of the Blood Center of California’s Medical Advisory Committee, and serves on educational committees for America’s Blood Centers and AABB. This presentation will be available on SBC’s YouTube channel at a later date. Check out some of our past Café Sci presenters on our YouTube page here: youtube.com/user/stanfordbloodcenter. Please note that the views and opinions presented at Café Scientifique do not necessarily reflect those of Stanford Blood Center.
New Law for Employers
The full text of the FFCRA can be found here.
The FFCRA is a new federal law that requires employers with fewer than 500 employees to provide two new paid leave benefits for eligible employees affected by the COVID-19 virus in 2020. This applies only to those employees (not already laid off) who are home sick. The leave requirements generally provide paid sick time or paid leave under certain circumstances (as described more fully in the notice poster, link #4, below). The FFCRA also provides tax credits that may help employers provide the paid leave benefits.
The FFCRA helps the U.S. combat workplace effects of COVID-19 by reimbursing American private employers that have fewer than 500 employees with tax credits for the cost of providing employees with paid leave, taken for specified reasons related to COVID-19. The law enables employers to keep workers (who are home sick with COVID-19 related illness and therefore unable to work, even remotely) on their payrolls, while at the same time ensuring that workers are not forced to choose between their paychecks and the public health measures needed to combat the virus. The Departmnt's Wage and Hour Division administers the paid leave portions of the FFCRA.
If an employer has fewer than 50 employees and providing the paid leave benefits would jeopardize the viability of the business as a going concern, the small business exemption may apply. Employers who believe they qualify for the exemption should document why the business meets the exemption criteria unless and until the Department of Labor issues additional guidance on claiming the exemption.
Effective April 1, 2020, employers are required to properly notify their employees of the new FFCRA leave benefits and implement the requirements.
Below are links to important resources that contain compliant employee notices, guidance, and recommendations for employers subject to the FFCRA.
- Department of Labor: COVID-19 and the American Workplace
- Fact Sheet: FFCRA – Employee Paid Leave Rights (in English)
- Fact Sheet: FFCRA – Employer Paid Leave Requirements (in English)
- Compliant FFCRA notice poster for private-sector employees (in English)
- Department of Labor FAQ for the FFCRA employee notice poster
courtesy of Montgomery & Hansen, LLP